Dan W. Gladney - Jul 22, 2021 Form 4 Insider Report for ReShape Lifesciences Inc. (RSLS)

Role
Director
Signature
/s/Dan W. Gladney
Stock symbol
RSLS
Transactions as of
Jul 22, 2021
Transactions value $
-$598,000
Form type
4
Date filed
9/17/2021, 06:37 PM
Previous filing
Jun 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RSLS Common Stock, $0.001 par value per share Award $0 +484K $0.00 484K Jul 22, 2021 Direct F1
transaction RSLS Common Stock, $0.001 par value per share Sale -$598K -200K -41.33% $2.99 284K Sep 10, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares will vest and be issued with respect to 241,961 shares on each of July 22, 2021 and July 22, 2022 pursuant to a restricted stock unit granted under the ReShape Lifesciences Inc. Second Amended and Restated 2003 Stock Incentive Plan.
F2 A portion of these shares were sold to cover taxes in connection with the vesting of restricted stock units.